Suppr超能文献

人类肾上腺髓质和嗜铬细胞瘤中的血管加压素受体。

Vasopressin receptors in human adrenal medulla and pheochromocytoma.

作者信息

Grazzini E, Breton C, Derick S, Andres M, Raufaste D, Rickwaert F, Boccara G, Colson P, Guérineau N C, Serradeil-le Gal C, Guillon G

机构信息

INSERM U-469, CCIPE, Montpellier, France.

出版信息

J Clin Endocrinol Metab. 1999 Jun;84(6):2195-203. doi: 10.1210/jcem.84.6.5775.

Abstract

The nature of vasopressin (VP) receptors present in normal and tumoral human adrenal was investigated using various experimental approaches. Specific VP-binding sites were detected by autoradiography using [3H]arginine VP as a radioligand in adrenal cortex and medulla. The V1a receptor subtype was expressed in the two parts of the gland, as shown by pharmacological studies and RT-PCR experiments. By contrast, the V1b receptor subtype was only expressed in medullary chromaffin cells. This was confirmed by the characterization of V1b transcripts detected in adrenal medulla tissues. In pheochromocytoma, we also detected functional V1b receptors. These receptors triggered intracellular calcium mobilization from intracellular pools and were involved in catecholamine secretion. Binding experiments performed on pheochromocytoma plasma membrane preparations also revealed V1a vasopressin-binding sites, whose roles and cellular localization have not yet been determined. RT-PCR experiments confirmed these data; 100% and 80% of the five tumors tested exhibited V1a and V1b transcripts, respectively. Perifusion experiments also demonstrated that some pheochromocytomas may secrete large amounts of VP. Our findings imply that VP locally secreted by human adrenal medulla may regulate adrenal function by acting on V1a or V1b receptors. More interestingly, we demonstrate that one pheochromocytoma oversecretes VP. In this particular case, this may contribute to the increase in blood pressure observed.

摘要

我们采用多种实验方法研究了正常和肿瘤性人类肾上腺中存在的血管加压素(VP)受体的性质。使用[3H]精氨酸血管加压素作为放射性配体,通过放射自显影在肾上腺皮质和髓质中检测到特异性VP结合位点。药理学研究和逆转录聚合酶链反应(RT-PCR)实验表明,V1a受体亚型在肾上腺的这两个部分均有表达。相比之下,V1b受体亚型仅在髓质嗜铬细胞中表达。这一点通过对肾上腺髓质组织中检测到的V1b转录本的特性分析得到了证实。在嗜铬细胞瘤中,我们也检测到了功能性V1b受体。这些受体触发细胞内钙从细胞内储存库的动员,并参与儿茶酚胺的分泌。对嗜铬细胞瘤质膜制剂进行的结合实验还揭示了V1a血管加压素结合位点,其作用和细胞定位尚未确定。RT-PCR实验证实了这些数据;所测试的5个肿瘤中,分别有100%和80%表现出V1a和V1b转录本。灌流实验也表明,一些嗜铬细胞瘤可能分泌大量的血管加压素。我们的研究结果表明,人类肾上腺髓质局部分泌的血管加压素可能通过作用于V1a或V1b受体来调节肾上腺功能。更有趣的是,我们证明了一个嗜铬细胞瘤过度分泌血管加压素。在这种特殊情况下,这可能导致所观察到的血压升高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验